ICS 2017 Scientific Podium Short Oral Session S15 - Male Lower Urinary Tract Dysfunction

Speakers
	Wednesday 13th September 2017
	16:30 - 18:00
	Cavaniglia B Capacity: 400
	Lunch provided
L Laurence Stewart ICS Chair F Ferdinando Fusco ICS Chair

16:30

#270 Patient Attitudes towards Deprescribing of alpha-blockers and willingness to participate in a discontinuation trial

Presenter: Malou Edelman

Edelman M¹, Blanker M¹, Jellema P¹, Hak E², Denig P³
1. University Medical Center Groningen, dept of General Practice, 2. University of Groningen, Groningen Research Institute of Pharmacy, 3. University of Groningen, Clinical pharmacy & pharmacology
Benign Prostatic Hyperplasia (BPH), Conservative Treatment, Male, Voiding Dysfunction , Outcomes Research Methods

16:37

#271 Effects of withdrawing dutasteride on serum testosterone and lower urinary tract symptoms

Presenter: Mamoru Hashimoto

Hashimoto M¹, Shimizu N¹, Matsumura N¹, Hongoh S¹, Sugimoto K¹, Minami T¹, Nozawa M¹, Yoshimura K¹, Uemura H¹, Tahara H², Hirayama A³
1. Department of Urology, Kindai University Faculty of Medicine, 2. Department of Urology, Mimihara General Hospital, 3. Department of Urology,Nara Hospital Kindai University Faculty of Medicine
Benign Prostatic Hyperplasia (BPH), Male, Bladder Outlet Obstruction

16:45

#272 Effects of a β3-adrenoceptor agonist on relaxation of the human prostate in vitro

Presenter: Takahisa Suzuki

Suzuki T¹, Otsuka A², Matsumoto R³, Furuse H², Miyake H², Ozono S²
1. Hamamatsu University School of Medicine, University of Pittsburgh, 2. Hamamatsu University School of Medicine, 3. Chutoen General Medical Center
Basic Science, Benign Prostatic Hyperplasia (BPH), Male, Pharmacology

16:52

#273 Mirabegron as a treatment for overactive bladder symptoms in men: Efficacy and safety results from a multicenter, randomized, double-blind, placebo-controlled, parallel comparison phase IV study (MIRACLE study).

Presenter: Dong Gil Shin

Kim H W¹, Shin D G¹, Yoon S J², Song S H³, Kim Y H⁴, Lee Y G⁵, Joo K J⁶, Bae J H⁷, Kang T W⁸, Jeong S⁹, Woo S H¹⁰, Kim S W¹¹
1. Pusan National University Hospital, 2. Gacheon University Gil Medical Center, 3. Asan Medical Center, 4. Soon Chun Hyang University Bucheon Hospital, 5. Hallym University Kangnam Sacred Heart Hospital, 6. Kangbuk Samaung Hospital, 7. Korea University Ansan hospital, 8. Chonnam National University Hospital, 9. Seoul National University Bundang Hospital, 10. Eulji University Hospital, 11. Seoul National University Hospital
Clinical Trial, Overactive Bladder, Questionnaire, Voiding Diary

17:00

#274 Combination therapy of Tamsulosin with Solifenacin reduces prostate vascular density while Tamsulosin monotherapy increases prostate perfusion in patients with predominately storage LUTS: results of a pilot study

Presenter: Vasileios Sakalis

Sakalis V¹, Vouros I², Salpiggidis G², Apostolidis A³
1. Salisbury NHS Trust, Duke of Cornwall Spinal Treatment Center, 2. Hippokrateion General Hospital of Thessaloniki, Greece, 3. Papageorgiou University Hospital of Thessaloniki, Greece
Benign Prostatic Hyperplasia (BPH), Imaging, Overactive Bladder

17:07

#275 Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia, based on a urodynamic study

Presenter: Yoshihisa Matsukawa

Matsukawa Y¹, Majima T¹, Funahashi Y¹, Matsuo K¹, Yamamoto T¹, Gotoh M¹
1. Department of Urology, Nagoya University Graduate School of Medicine, Japan
Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Detrusor Overactivity, Prospective Study

17:15

#276 Preoperative serum low density lipoprotein cholesterol / high density lipoprotein cholesterol ratio is a useful predictor of lower urinary tract dysfunction after robot-assisted radical prostatectomy

Presenter: Hidenori Akaihata

Akaihata H¹, Haga N¹, Hata J¹, Kushida N¹, Aikawa K¹, Kojima Y¹
1. Fukushima medical university
Voiding Dysfunction , Detrusor Overactivity, Underactive Bladder

17:22

#277 Comparative urinary function and interventions for voiding dysfunction after radical perineal prostatectomy versus robotic-assisted laparoscopic prostatectomy

Presenter: Alyssa Greiman

Greiman A¹, Rawls W¹, Clarke H¹, Prasad S¹, Savage S¹, Keane T¹, Cox L¹
1. Medical University of South Carolina
Incontinence, Male, Surgery, Retrospective Study

17:30

#278 Effective measurement of lower urinary tract symptoms including urinary incontinence, after surgery, radiotherapy or active monitoring treatment for localised prostate cancer

Presenter: Jenny Donovan

Donovan J¹, Metcalfe C¹, Young G¹, Lane A¹, Neal D², Hamdy F²
1. University of Bristol, 2. University of Oxford
Incontinence, Voiding Dysfunction , Clinical Trial, Outcomes Research Methods, Male

17:37

#279 How can we predict the proper timing of the holmium laser enucleation of the prostate (HoLEP) ?

Presenter: Ji Sung Shim

Shim J S¹, Oh M M¹, Tae B S¹, Bae J H¹, Kang S H¹, Lee J G¹
1. Department of Urology, Korea University College of Medicine
Benign Prostatic Hyperplasia (BPH), Male, Voiding Dysfunction

17:45

#280 Holmium laser enucleation of the prostate as a palliative management for refractory bladder outlet obstruction in patients with advanced prostate cancer

Presenter: Jeong Zoo Lee

Shin D G¹, Kim H W¹, Lee W², Oh T H³, Yoon C S⁴, Choi S⁵, Cho W Y⁶, Chung M K⁷, Lee J Z¹
1. Pusan National University Hospital, 2. Dongnam Institute of Radiology and Medical Science, 3. Samsung Changwon Hospital, 4. BHS Han-seo Hospital, 5. Kosin University College of Medicine, 6. Dong-A University Hospital, 7. Pusan National University Yangsan Hospital
Bladder Outlet Obstruction , Male, Surgery

17:52

#281 Comparison of Postoperative Outcomes according to Intravesical Prostatic Protrusion in Patients with Benign Prostatic Hyperplasia who underwent Holmium laser enucleation of the prostate

Presenter: Eun Sang Yoo

Yoo E S¹, Chung J¹, Ha Y¹, Choi S H¹, Lee J N¹, Kim B S¹, Kim H T¹, Kim T¹, Kwon T G¹, Chung S K¹, Seo Y J²
1. School of Medicine, Kyungpook National University, 2. College of Medicine, Dongguk University
Benign Prostatic Hyperplasia (BPH), Surgery, Imaging

Content Visitors (staff only)

Male Lower Urinary Tract Dysfunction

Scientific Podium Short Oral Session S15

Session Schedule

Comments

Chat